| |
| |
|
| Insider
Information: |
Eastham Karin |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
195,379 |
|
|
Indirect Shares
|
1,000 |
|
|
| Direct
Value |
$2,136,105 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
196,379 |
|
|
| Total
Value |
$2,136,105 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Diversa Corp |
VRNM |
Sr. VP Finance, CFO & ... |
2004-04-29 |
6,419 |
2004-04-29 |
1,000 |
Premium* |
|
|
Sgx Pharmaceuticals, Inc. |
SGXP |
Director |
2008-08-20 |
0 |
|
0 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2019-05-23 |
10,049 |
2008-05-16 |
0 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2023-01-13 |
109,047 |
2009-05-29 |
0 |
Premium* |
|
|
Trius Therapeutics Inc |
TSRX |
Director |
2013-09-11 |
0 |
2013-09-11 |
0 |
Premium* |
|
|
Amylin Pharmaceuticals Inc |
AMLN |
Director |
2012-08-08 |
0 |
2011-05-24 |
0 |
Premium* |
|
|
Veracyte, Inc. |
VCYT |
Director |
2024-04-01 |
33,125 |
2021-11-01 |
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Director |
2022-09-16 |
23,233 |
2018-09-27 |
0 |
Premium* |
|
|
Personalis, Inc. |
PSNL |
Director |
2022-05-17 |
13,506 |
2021-05-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
122 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ILMN |
Illumina Inc |
Director |
• • – |
2016-06-01 |
4 |
OE |
$36.29 |
$181,450 |
D/D |
5,000 |
17,424 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
• • – |
2019-01-02 |
4 |
AS |
$291.02 |
$1,470,381 |
D/D |
(5,000) |
10,838 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2021-12-17 |
4 |
AS |
$45.00 |
$225,000 |
D/D |
(5,000) |
8,720 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2021-12-17 |
4 |
OE |
$12.12 |
$60,600 |
D/D |
5,000 |
13,720 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2014-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,577 |
39,047 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2014-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,646 |
35,970 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2011-03-17 |
4 |
AS |
$62.80 |
$379,188 |
D/D |
(6,000) |
4,200 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2011-03-17 |
4 |
OE |
$13.30 |
$96,900 |
D/D |
6,000 |
4,676 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Director |
– • – |
2012-03-27 |
4 |
OE |
$3.50 |
$21,000 |
D/D |
6,000 |
18,114 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Director |
– • – |
2012-08-08 |
4 |
D |
$31.00 |
$186,000 |
D/D |
(6,000) |
0 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Director |
– • – |
2013-09-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,000) |
0 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-06-02 |
4 |
AS |
$153.79 |
$945,337 |
D/D |
(6,000) |
9,826 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-06-02 |
4 |
OE |
$17.58 |
$105,450 |
D/D |
6,000 |
15,826 |
0 |
- |
|
| VRNM |
Diversa Corp |
Sr. VP Finance, CFO, & Sec |
• – – |
2004-01-14 |
4 |
AS |
$10.50 |
$65,022 |
D/D |
(6,100) |
17,531 |
|
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2021-02-25 |
4 |
OE |
$4.00 |
$25,000 |
D/D |
6,250 |
6,250 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2021-02-25 |
4 |
AS |
$60.03 |
$379,359 |
D/D |
(6,250) |
0 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2019-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
15,000 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2009-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2010-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
15,000 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-09-27 |
4 |
A |
$0.00 |
$0 |
D/D |
8,500 |
8,500 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2021-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
8,720 |
8,720 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2011-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
69,000 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2020-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
9,100 |
24,100 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2023-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
9,674 |
33,125 |
0 |
- |
|
| VRNM |
Diversa Corp |
officerTitle |
• – – |
2003-07-10 |
4 |
AS |
$11.44 |
$115,797 |
I/I |
(10,000) |
37,419 |
|
- |
|
122 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
